Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Mise à jour : Il y a 5 ans
Référence : NCT00435448

Extrait

The purpose of this study is to evaluate the efficacy of lonidamine (50mg, 150mg) compared to placebo in subjects with symptomatic BPH.


Critère d'inclusion

  • benign prostatic hyperplasia ,Enlarged prostate


Liens